Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ · Healthcare
Harmony Biosciences Holdings, Inc. Revenue 2020–2025
Harmony Biosciences Holdings, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Harmony Biosciences Holdings, Inc. revenue for the quarter ending March 31, 2026 was 215.4 M, a 16.59% increase year-over-year.
- Harmony Biosciences Holdings, Inc. revenue for the twelve months ending March 31, 2026 was 899.1 M.
- Harmony Biosciences Holdings, Inc. annual revenue for 2025 was 868.5 M, a 21.51% increase from 2024.
- Harmony Biosciences Holdings, Inc. annual revenue for 2024 was 714.7 M, a 22.80% increase from 2023.
- Harmony Biosciences Holdings, Inc. annual revenue for 2023 was 582.0 M, a 32.93% increase from 2022.
- Harmony Biosciences Holdings, Inc. annual revenue for 2022 was 437.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Harmony Biosciences Holdings, Inc. Earnings — FAQ
Harmony Biosciences Holdings, Inc. (HRMY) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HRMY's earnings history?
The chart and table above show Harmony Biosciences Holdings, Inc.'s earnings by year and by quarter, including the growth rate.